Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
DEVON, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies […]